|
|
||||||||
RESEARCH COMMUNICATION |
a Research Institute for Internal Medicine, Medical Department A, The National Hospital, University of Oslo, Norway
b Section of Clinical Immunology and Infectious Diseases, Medical Department A, The National Hospital, University of Oslo, Norway
Besides their role in hemostasis, platelets are involved in inflammatory and immunological processes, and we hypothezise that platelet activation may play an immunopathogenetic role in HIV-1 infection. Blood was drawn from 15 controls and 20 HIV-1-infected patients with normal platelet counts, classified into groups of non-AIDS and AIDS. Platelet activation was detected using flow cytometry with mAbs against the release markers P-selectin and CD63, mAb against GPIb, and the probe annexin V detecting surface exposure of aminophospholipids. The amount of microvesicles was measured using mAb against GPIIIa. Compared to controls, blood samples from HIV-1-infected patients showed significantly enhanced levels of microvesicles and activated platelets as detected by their exposure of P-selectin, CD63, and aminophospholipids, as well as reduction in GPIb expression. Increased expression of P-selectin and amounts of microvesicles were most pronounced in advanced clinical and immunological disease. When studying the effect of HIV-1 protease inhibitor therapy (indinavir) on platelet activation, we found that concomitant with a profound decrease in plasma viral load, there was a near normalization of several of the parameters reflecting enhanced platelet activation. Finally, we demonstrated that platelets may be an important source of the chemokine RANTES in HIV-1-infected patients. Although both unstimulated and SFLLRN-stimulated platelets from asymptomatic patients had enhanced release of RANTES, platelets from AIDS patients were characterized by markedly enhanced spontaneous, but decreased SFLLRN-stimulated release of this chemokine. Taken together, these results, which demonstrate for the first time increased platelet activation in HIV-1-infected patients with normal platelet counts, may represent a previously unrecognized immunopathogenic factor in HIV-1 infection.Holme, P. A., Müller, F., Solum, N. O., Brosstad, F., Frøland, S. S., Aukrust, P Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. FASEB J. 12, 7990 (1998)
Key Words: HIV RANTES platelets antiretroviral therapy P-selection
This article has been cited by other articles:
![]() |
J. Graff, N. von Hentig, K. Kuczka, C. Angioni, P. Gute, S. Klauke, E. Babacan, and S. Harder Significant effects of tipranavir on platelet aggregation and thromboxane B2 formation in vitro and in vivo J. Antimicrob. Chemother., February 1, 2008; 61(2): 394 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Otterdal, A. K. Andreassen, A. Yndestad, E. Oie, W. J. Sandberg, C. P. Dahl, T. M. Pedersen, T. Ueland, L. Gullestad, F. R. Brosstad, et al. Raised LIGHT Levels in Pulmonary Arterial Hypertension: Potential Role in Thrombus Formation Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 202 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Nardi, Y. Gor, S. J. Feinmark, F. Xu, and S. Karpatkin Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase Blood, September 15, 2007; 110(6): 1989 - 1996. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Wachtman, R. L. Skolasky, P. M. Tarwater, D. Esposito, G. Schifitto, K. Marder, M. P. McDermott, B. A. Cohen, A. Nath, N. Sacktor, et al. Platelet Decline: An Avenue for Investigation Into the Pathogenesis of Human Immunodeficiency Virus Associated Dementia Arch Neurol, September 1, 2007; 64(9): 1264 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nomura, K. Ishii, Y. Kamitsuji, N. Uoshima, E. Ishikawa, H. Kitayama, and K. Hayashi Elevation of Activated Platelet-Dependent Chemokines in Patients With Anti-CD20 Monoclonal Antibody (Rituximab)-Treated Non-Hodgkin's Lymphoma Clinical and Applied Thrombosis/Hemostasis, April 1, 2007; 13(2): 206 - 212. [Abstract] [PDF] |
||||
![]() |
E. Cavusoglu, C. Eng, V. Chopra, L. T. Clark, D. J. Pinsky, and J. D. Marmur Low Plasma RANTES Levels Are an Independent Predictor of Cardiac Mortality in Patients Referred for Coronary Angiography Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 929 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Sui, L. F. Sniderhan, G. Schifitto, R. P. Phipps, H. A. Gelbard, S. Dewhurst, and S. B. Maggirwar Functional Synergy between CD40 Ligand and HIV-1 Tat Contributes to Inflammation: Implications in HIV Type 1 Dementia J. Immunol., March 1, 2007; 178(5): 3226 - 3236. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Smith, J. K. Damas, K. Otterdal, E. Oie, W. J. Sandberg, A. Yndestad, T. Waehre, H. Scholz, K. Endresen, P. S. Olofsson, et al. Increased Levels of Neutrophil-Activating Peptide-2 in Acute Coronary Syndromes: Possible Role of Platelet-Mediated Vascular Inflammation J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1591 - 1599. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Holven, J. K. Damas, A. Yndestad, T. Waehre, T. Ueland, B. Halvorsen, L. Heggelund, W. J. Sandberg, A. G. Semb, S. S. Froland, et al. Chemokines in Children With Heterozygous Familiar Hypercholesterolemia: Selective Upregulation of RANTES Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 200 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sun, S. F. Abdelwahab, G. K. Lewis, and A. Garzino-Demo Recall antigen activation induces prompt release of CCR5 ligands from PBMC: implication in memory responses and immunization Int. Immunol., November 1, 2004; 16(11): 1623 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nomura, N. Inami, S. Kanazawa, T. Iwasaka, and S. Fukuhara Elevation of Platelet Activation Markers and Chemokines during Peripheral Blood Stem Cell Harvest with G-CSF Stem Cells, September 1, 2004; 22(5): 696 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Damas, T. Waehre, A. Yndestad, K. Otterdal, A. Hognestad, N. O. Solum, L. Gullestad, S. S. Froland, and P. Aukrust Interleukin-7-Mediated Inflammation in Unstable Angina: Possible Role of Chemokines and Platelets Circulation, June 3, 2003; 107(21): 2670 - 2676. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Llano, J. Barretina, A. Gutierrez, B. Clotet, and J. A. Este Interleukin-7-Dependent Production of RANTES That Correlates with Human Immunodeficiency Virus Disease Progression J. Virol., April 1, 2003; 77(7): 4389 - 4395. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Matsumoto, S. Nomura, H. Kamihata, Y. Kimura, and T. Iwasaka Association of Platelet-Derived Microparticles With C-C Chemokines on Vascular Complication in Patients With Acute Myocardial Infarction Clinical and Applied Thrombosis/Hemostasis, July 1, 2002; 8(3): 279 - 286. [Abstract] [PDF] |
||||
![]() |
T. Youssefian, A. Drouin, J.-M. Masse, J. Guichard, and E. M. Cramer Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation Blood, May 13, 2002; 99(11): 4021 - 4029. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. L. Gear, S. Suttitanamongkol, D. Viisoreanu, R. K. Polanowska-Grabowska, S. Raha, and D. Camerini Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function Blood, February 15, 2001; 97(4): 937 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ahmad, J. Menezes, L. Knafo, and A. Ahmad Activated human platelets express Fas-L and induce apoptosis in Fas-positive tumor cells J. Leukoc. Biol., January 1, 2001; 69(1): 123 - 128. [Abstract] [Full Text] |
||||
![]() |
K. J. Clemetson, J. M. Clemetson, A. E. I. Proudfoot, C. A. Power, M. Baggiolini, and T. N. C. Wells Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets Blood, December 15, 2000; 96(13): 4046 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. RUSNATI, G. TARABOLETTI, C. URBINATI, G. TULIPANO, R. GIULIANI, M. P. MOLINARI-TOSATTI, B. SENNINO, M. GIACCA, M. TYAGI, A. ALBINI, et al. Thrombospondin-1/HIV-1 Tat protein interaction: modulation of the biological activity of extracellular Tat FASEB J, October 1, 2000; 14(13): 1917 - 1930. [Abstract] [Full Text] |
||||
![]() |
J. K. Damas, L. Gullestad, T. Ueland, N. O. Solum, S. Simonsen, S. S Froland, and P. Aukrust CXC-chemokines, a new group of cytokines in congestive heart failure -- possible role of platelets and monocytes Cardiovasc Res, January 14, 2000; 45(2): 428 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. O. Solum Procoagulant Expression in Platelets and Defects Leading to Clinical Disorders Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2841 - 2846. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Garzino-Demo, R. B. Moss, J. B. Margolick, F. Cleghorn, A. Sill, W. A. Blattner, F. Cocchi, D. J. Carlo, A. L. DeVico, and R. C. Gallo Spontaneous and antigen-induced production of HIV-inhibitory beta -chemokines are associated with AIDS-free status PNAS, October 12, 1999; 96(21): 11986 - 11991. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Aukrust, F. Muller, T. Ueland, T. Berget, E. Aaser, A. Brunsvig, N. O. Solum, K. Forfang, S. S. Froland, and L. Gullestad Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina : Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes Circulation, August 10, 1999; 100(6): 614 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Aukrust, T. Ueland, F. Muller, A. K. Andreassen, I. Nordoy, H. Aas, J. Kjekshus, S. Simonsen, S. S. Froland, and L. Gullestad Elevated Circulating Levels of C-C Chemokines in Patients With Congestive Heart Failure Circulation, March 31, 1998; 97(12): 1136 - 1143. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |